APLM
Price
$22.83
Change
+$5.33 (+30.46%)
Updated
Jun 22 closing price
Capitalization
50.14M
Intraday BUY SELL Signals
IPHA
Price
$1.81
Change
-$0.00 (-0.00%)
Updated
Jun 22 closing price
Capitalization
173.21M
86 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

APLM vs IPHA

APLM vs IPHA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
APLM vs. IPHA commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLM is a Hold and IPHA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 23, 2026
Stock price -- (APLM: $22.83 vs. IPHA: $1.83)
Brand notoriety: APLM and IPHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLM: 391% vs. IPHA: 9%
Market capitalization -- APLM: $50.14M vs. IPHA: $173.21M
APLM [@Biotechnology] is valued at $50.14M. IPHA’s [@Biotechnology] market capitalization is $173.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLM’s FA Score shows that 0 FA rating(s) are green whileIPHA’s FA Score has 0 green FA rating(s).

  • APLM’s FA Score: 0 green, 5 red.
  • IPHA’s FA Score: 0 green, 5 red.
According to our system of comparison, both APLM and IPHA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLM’s TA Score shows that 5 TA indicator(s) are bullish while IPHA’s TA Score has 3 bullish TA indicator(s).

  • APLM’s TA Score: 5 bullish, 4 bearish.
  • IPHA’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, APLM is a better buy in the short-term than IPHA.

Price Growth

APLM (@Biotechnology) experienced а +64.84% price change this week, while IPHA (@Biotechnology) price change was +1.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.11%. For the same industry, the average monthly price growth was +3.26%, and the average quarterly price growth was +1969.89%.

Reported Earning Dates

IPHA is expected to report earnings on Sep 17, 2026.

Industries' Descriptions

@Biotechnology (+7.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IPHA($173M) has a higher market cap than APLM($50.1M). APLM YTD gains are higher at: 22.118 vs. IPHA (4.286).
APLMIPHAAPLM / IPHA
Capitalization50.1M173M29%
EBITDA-56.38MN/A-
Gain YTD22.1184.286516%
P/E RatioN/AN/A-
Revenue0N/A-
Total CashN/AN/A-
Total Debt4.72MN/A-
FUNDAMENTALS RATINGS
IPHA: Fundamental Ratings
IPHA
OUTLOOK RATING
1..100
29
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
38
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APLMIPHA
RSI
ODDS (%)
Bearish Trend 1 day ago
30%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
61%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
53%
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
53%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
48%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
75%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 29 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
53%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
APLM
Daily Signal:
Gain/Loss:
IPHA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OWSMX18.21N/A
N/A
Old Westbury Small & Mid Cap Strategies
TOLCX16.34N/A
N/A
DWS RREEF Global Infrastructure C
CILGX14.85N/A
N/A
Clarkston Institutional
EMREX27.53N/A
N/A
JPMorgan Emerging Mkts Rsrch Enh Eq I
USERX27.63-0.10
-0.36%
US Global Investors Gld & Prec Mtls

APLM and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLM has been loosely correlated with SNTI. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if APLM jumps, then SNTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLM
1D Price
Change %
APLM100%
+30.47%
SNTI - APLM
47%
Loosely correlated
+4.91%
HCWB - APLM
45%
Loosely correlated
+6.42%
PRAX - APLM
39%
Loosely correlated
+7.33%
MGX - APLM
37%
Loosely correlated
-0.83%
IPHA - APLM
36%
Loosely correlated
+0.83%
More

IPHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPHA has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IPHA jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPHA
1D Price
Change %
IPHA100%
+0.83%
MDGL - IPHA
43%
Loosely correlated
+1.59%
FENC - IPHA
41%
Loosely correlated
+5.19%
APLM - IPHA
36%
Loosely correlated
+30.47%
CCXI - IPHA
34%
Loosely correlated
+0.63%
COGT - IPHA
33%
Poorly correlated
+3.72%
More